It was a pleasure to meet with Alba Ramírez Sarmiento and Mauricio Orozco-Levi at ERS 2019 in Madrid, who discussed the latest trial results for the new invention device (SUPRAtube) for mechanical ventilation.
Questions
1. What are the main risks for patients receiving mechanical ventilation? (0:05)
2. How does the new invention device (SUPRAtube) in the SUPRAnav trial potentially mitigate the risk of ventilator-associated pneumonia? (0:40)
3. What was the objective of the SUPRAnav trial and how was it designed to achieve this objective? (1:27)
4. Please outline the key results of the SUPRAnav trial (1:56)
5. What further work is required and what is the potential impact of these results for patients? (3:23)
6. What are the key take-home messages from the presentation? (5:09)
Speaker disclosures: Alba Ramírez Sarmiento and Mauricio Orozco-Levi have nothing to declare in relation to this video interview.
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Respiratory Society (ERS) International Congress 2019, Madrid, Spain.
